Royalty Pharma plc (RPRX) reports Q1 results
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $58.52 +0.14%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q1 results. Revenue for the quarter came in at $684 million versus the consensus estimate of $806.84 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- Progress Software completes $400M acquisition of Domo's data platform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
